Axxcess Wealth Management »

Allogene Therapeutics shares owned by Axxcess Wealth Management

Quarter-by-quarter ownership of Allogene Therapeutics (ALLO) shares owned by Axxcess Wealth Management from 13F filings

Historical chart of Axxcess Wealth Management investment in Allogene Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Allogene Therapeutics held by Axxcess Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Allogene Therapeutics by Axxcess Wealth Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $34k 11k 3.21

More positions owned by Axxcess Wealth Management

Vanguard Index Fds Large Cap Etf (VV)
Servicenow (NOW)
Ishares Tr Core Us Aggbd Et (AGG)
Apple Put Option (AAPL)
Ishares Tr Core Msci Intl (IDEV)
Microsoft Corporation (MSFT)
Pacer Fds Tr Us Cash Cows 100 (COWZ)
Spdr Ser Tr Bloomberg 1-3 Mo (BIL)
J P Morgan Exchange Traded F Ultra Shrt Inc (JPST)
Vanguard Index Fds Mid Cap Etf (VO)
Vanguard Scottsdale Fds Total Corp Bnd (VTC)
Ishares Tr TRS FLT RT BD (TFLO)
Ishares Tr Us Home Cons Etf (ITB)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)
Ishares Tr Core S&p Mcp Etf (IJH)

View all positions for Axxcess Wealth Management

Top funds holding Allogene Therapeutics

Tpg Gp A
Vanguard Group
Jpmorgan Chase & Co
PRIMECAP Management Company
Citadel Advisors
Goldman Sachs Group
T. Rowe Price Associates
Two Sigma Investments
Millennium Management
Vida Ventures Advisors
Dimensional Fund Advisors
Two Sigma Advisers
Caxton Associates
Nordea Investment Management Ab
Charles Schwab Investment Management

View all funds holding Allogene Therapeutics